U.S. Tech Hardware Stock News

How LGI Homes Stock Has Been Moving LGI Homes (LGIH) has recently seen mixed share performance, with a 3.2% decline over the past day and a 4.8% decline over the past week, alongside a gain over the past month. Over the past 3 months the stock has recorded a gain, while the year-to-date figure is also positive. In contrast, the past year, 3-year, and 5-year total returns all show declines. See our latest analysis for LGI Homes. At a share price of $51.21, LGI Homes has seen short term...

Recently, ZIM Integrated Shipping Services reported that its short interest as a percentage of float fell by 14.99%, to 15.54%, still well above the peer group average of 2.71%. This pullback in short positioning, while remaining elevated versus peers, highlights a shift in sentiment that could be especially important for such a heavily shorted stock. We will now examine how this sharp reduction in short interest shapes ZIM Integrated Shipping Services’ investment narrative and investor...

Palantir Technologies (NasdaqGS:PLTR) has entered a large, multi-year commercial partnership with South Korea's HD Hyundai, covering shipbuilding, construction, robotics, and electric systems. The agreement places Palantir's AI platforms at the center of HD Hyundai's group-wide digital transformation plans. Separately, Palantir is working on sovereign-grade AI data centers across Europe, the Middle East, and Africa for commercial and government use. Palantir, known for its data and AI...

Regeneron Pharmaceuticals (REGN) is back in focus after the approval of its high dose Eylea HD, which cuts injection frequency, combined with continued Dupixent momentum and fresh bullish commentary from analysts and long term shareholders. See our latest analysis for Regeneron Pharmaceuticals. Those Eylea HD and Dupixent updates arrive as Regeneron’s 90 day share price return of 15.14% contrasts with a softer year to date share price return of a 2.93% decline, while the 1 year total...

Arrowhead Pharmaceuticals (ARWR) has drawn fresh attention after China’s NMPA approved its drug Redemplo for familial chylomicronemia syndrome. This marks the therapy’s third clearance, following earlier approvals in the US and Canada. See our latest analysis for Arrowhead Pharmaceuticals. At a share price of US$67.05, Arrowhead has given investors a 69.53% 90 day share price return. The 1 year total shareholder return of 231.11% and 3 year total shareholder return of 101.47% underline how...

On January 22, 2026, Eastern Bankshares reported Q4 2025 earnings that exceeded analyst expectations, detailed higher full-year net interest income of US$828.6 million, and confirmed a regular quarterly cash dividend of US$0.13 per share payable on March 20, 2026 to shareholders of record on March 6, 2026. The company also completed a US$55.4 million buyback of 3,100,000 shares, reported lower net charge-offs of US$9.8 million for Q4 2025, and highlighted record wealth assets under...

L3Harris Technologies has raised its quarterly cash dividend from US$1.20 to US$1.25 per share, and the Pentagon has committed US$1.00 billion to its solid rocket motors business ahead of a planned Missile Solutions spin-off and IPO in the second half of 2026. Together, the higher dividend and the Department of Defense’s direct equity stake highlight L3Harris’s effort to reposition its portfolio around core defense technologies while still emphasizing shareholder returns. We’ll now examine...

Fidelity National Information Services (FIS) recently reshaped its business mix by selling its remaining Worldpay stake and buying Global Payments' issuer solutions arm, while lifting its 2025 revenue and earnings guidance to reflect operational progress. See our latest analysis for Fidelity National Information Services. Even after the recent portfolio reshuffle and upgraded 2025 guidance, the 1-year total shareholder return of 23.71% decline and 5-year total shareholder return of 47.69%...

United Airlines Holdings reported its fourth-quarter 2025 results, with revenue of US$15,397 million and net income of US$1,044 million, alongside record full-year revenue of US$59,070 million and earnings per share of US$10.20. Beyond the headline records, the company’s premium cabins delivered around 12% year-on-year revenue growth, and United became the only US airline to grow earnings per share over the year while also raising guidance for 2026. We’ll now examine how United’s upgraded...

In January 2026, IPG Photonics showcased a broad lineup of new laser solutions at the SPIE Photonics West Exhibition in San Francisco, spanning cleaning, welding, cutting, micro‑machining, semiconductor manufacturing, and directed energy applications. The introduction of ultra‑compact multi‑kilowatt lasers, deep UV and femtosecond sources, and integrated high‑power welding platforms underscores IPG Photonics’ push into higher‑precision manufacturing, defense, and EV battery production...

Why the recent news around West Pharmaceutical Services stock matters West Pharmaceutical Services (WST) has been in focus after recent commentary highlighted expected improvements in earnings estimates, a positive Zacks ranking, and solid demand for its proprietary drug delivery products and capacity expansion plans. See our latest analysis for West Pharmaceutical Services. Despite upbeat commentary around earnings estimates and strong demand for its drug delivery products, the share price...

Pursuit Attractions and Hospitality, Inc. previously announced it had entered into an agreement to sell its Flyover flying theater subsidiaries for US$78.40 million in cash, subject to regulatory approvals and including a US$10.00 million termination fee under certain conditions. This divestiture marks a meaningful reshaping of Pursuit’s attractions portfolio and signals potential capital redeployment within its wider hospitality and attractions businesses. We will now examine how the...

Preliminary 2025 loss guidance and recent share move JinkoSolar Holding (JKS) recently issued preliminary unaudited 2025 earnings guidance, indicating an estimated net loss for Jiangxi Jinko of RMB 5,900 million to RMB 6,900 million, with losses remaining sizeable even after excluding extraordinary items. The guidance followed a volatile stretch for the stock, including a decline over the past week following gains over the past 3 months. It provides investors with a clearer fundamental...

In January 2026, Guardian Pharmacy Services, Inc. reaffirmed its 2025 revenue guidance of US$1.43 billion to US$1.45 billion and issued new 2026 guidance of US$1.40 billion to US$1.42 billion. This updated outlook gives investors a clearer view of expected near-term revenue trends and reflects management’s willingness to quantify its forward plans. Next, we’ll examine how the reaffirmed 2025 outlook and newly issued 2026 revenue range shape Guardian Pharmacy Services’ investment...

Terex Corporation has appointed Namita Jindal as Senior Vice President and Chief AI and Data Officer, effective 19 January 2026, reporting directly to President and CEO Simon Meester and joining the Executive Leadership Team. By bringing in an executive with long experience in digital transformation and industrial automation, Terex is signaling a stronger focus on embedding AI and data into its operations and products. We will now examine how this leadership move, centered on AI and data...

WisdomTree, Inc. recently launched two new exchange-traded funds on Cboe, the WisdomTree Efficient TIPS Plus Gold Fund (GDT) and the WisdomTree Efficient Long/Short U.S. Equity Fund (WTLS), expanding its capital‑efficient lineup with expense ratios of 0.30% and 0.88%, respectively. By pairing inflation-linked Treasuries with gold and applying machine-learning-driven long/short equity overlays, these funds highlight WisdomTree’s focus on combining traditional exposures with innovative tools,...

UnitedHealth’s decision to return Affordable Care Act profits has put sector regulation in focus, raising questions about how any similar measures could reshape Centene (CNC) and its reliance on health exchange earnings. See our latest analysis for Centene. Against the backdrop of potential Affordable Care Act profit rebates, Centene’s share price has climbed, with a 30 day share price return of 13.77% and a 90 day share price return of 38.87%. In contrast, the 1 year total shareholder return...

In its latest reported quarter, Acushnet Holdings, maker of Titleist Pro V1 golf balls, delivered a 6% year-on-year revenue increase and exceeded analyst expectations on both sales and adjusted operating income. This combination of top-line growth and operational outperformance, set against generally resilient leisure products peers, highlighted the company’s ability to execute in a competitive consumer landscape. With recent gains in the share price, we’ll examine how Acushnet’s...

StepStone Group has recently announced plans to release its third-quarter fiscal 2026 results on February 5, 2026, and, through StepStone Real Estate, completed a US$250 million continuation vehicle with Blue Moon Capital Partners to operate and expand a portfolio of Class A senior housing communities. This combination of upcoming earnings disclosure and targeted senior housing expansion highlights how StepStone is positioning within specialized alternative assets alongside experienced...

Intuitive Surgical reported past fourth-quarter 2025 revenue of US$2.87 billion and net income of US$794.8 million, capping a full-year revenue of US$10.06 billion and net income of US$2.86 billion, both higher than the prior year. The company underscored rapid global uptake of its da Vinci 5 and Ion systems, with more than 3.1 million da Vinci procedures in 2025 and over 20 million such surgeries performed worldwide to date. We’ll now examine how this combination of strong earnings and...

Graco (GGG) heads into its fourth quarter earnings report today after the bell, with investors watching whether forecast revenue and EPS growth materializes following last quarter's revenue and EBITDA misses. See our latest analysis for Graco. At a share price of $86.55, Graco has seen a 30 day share price return of 3.78% and a 90 day gain of 6.34%, while the 3 year total shareholder return of 35.00% points to steadier long term momentum despite softer recent one day and one week moves. If...

Blue Gold Ltd recently benefited as gold and other precious metals climbed to record highs amid geopolitical tensions, economic uncertainty and expectations of Federal Reserve rate cuts. This surge in demand for gold highlights how macroeconomic and currency conditions can quickly shift investor attention toward producers like Blue Gold. We will now examine how heightened demand for gold, driven by geopolitical and economic uncertainty, influences Blue Gold’s broader investment...

KLA (KLAC) heads into its January 29 earnings release with expectations for year over year growth in earnings and revenue, as recent analyst estimate revisions and rating changes put guidance in sharp focus for investors. See our latest analysis for KLA. At a share price of US$1,512.78, KLA has seen a 30 day share price return of 18.22% and a 90 day share price return of 25.43%. Its 1 year total shareholder return of 117.12% and 5 year total shareholder return of more than 4x highlight strong...

Why PACCAR’s leadership and analyst attention matter right now PACCAR (PCAR) is back in focus after major research firms reiterated constructive views on the truck maker, even as recent commentary points to softer organic revenue and increased insider selling activity. For you as a shareholder or potential buyer, that split picture raises a practical question: how do upbeat external views square with concerns about the core business, and what might that mix mean for risk and return? See our...